Maris Gunars Hartmanis

Director/Board Member at XSPRAY PHARMA AB

Net worth: 123 202 $ as of 2024-04-29

71 year

100 connections

Health Technology

Distribution Services

Finance

Active connections

Name	Gender	Age	Linked companies	Collaboration
Eva Nilsagård	F	60	VITROLIFE AB XBRANE BIOPHARMA AB	7 years
Martin Åmark	M	44	XBRANE BIOPHARMA AB	9 years
Mats Danielsson	M	59	Royal Institute of Technology	6 years
Per Andersson	M	57	XSPRAY PHARMA AB	18 years
Pia Marions	F	61	VITROLIFE AB	11 years
Hans Bornefalk	M	49	Royal Institute of Technology	4 years
Christine Lind	F	50	XSPRAY PHARMA AB	5 years
Siavash Bashiri	M	41	XBRANE BIOPHARMA AB	9 years
Charlotta Ljungqvist	M	63	BioLamina AB BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. Royal Institute of Technology	6 years
Kerstin Hasselgren	F	63	XSPRAY PHARMA AB	5 years
Anders Lundblad	M	-	Royal Institute of Technology	4 years
Anders Lennart Tullgren	M	63	XBRANE BIOPHARMA AB	6 years
Lars Anders Lindblad	M	74	BioLamina AB BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.	6 years
Veronica Byfield Sköld	F	-	BioLamina AB BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.	3 years
Anders Olof Adolf Ekblom	M	70	XSPRAY PHARMA AB MEDIVIR AB	7 years
Mats Johan Peter Thorén	M	53	XBRANE BIOPHARMA AB	4 years
David Bernhard Sonnek	M	63	Royal Institute of Technology	6 years
Erik Börje Ekholm	M	61	Royal Institute of Technology	-
Sara Mazur	M	58	Royal Institute of Technology	-
Mats Gottfrid Magnusson	M	56	Royal Institute of Technology	-
Per Stefan Andersson-Engels	M	64	Royal Institute of Technology	28 years
Tuula Teeri	M	67	Royal Institute of Technology	-
Eva Elisabet Malmström Jonsson	M	58	Royal Institute of Technology	-
Lisa Margaretha Ericsson	F	51	Royal Institute of Technology	17 years
Bengt Stefan Ståhl	M	63	Royal Institute of Technology	-
Maria Edebrink	F	55	XBRANE BIOPHARMA AB	5 years
Michael Malkoch	M	-	Royal Institute of Technology	-
Xiaoli Hu	M	42	XBRANE BIOPHARMA AB	4 years
Rickard Ericsson	M	53	VITROLIFE AB	9 years
Monica Bellgran	F	58	Royal Institute of Technology	-
Dina Jurman	F	42	XBRANE BIOPHARMA AB	7 years
Andreas Konar	M	75	XSPRAY PHARMA AB	14 years
Helene Svahn	M	50	Royal Institute of Technology	16 years
Martin Ragnar	M	52	Royal Institute of Technology	-
Robert Molander	M	59	XSPRAY PHARMA AB	2 years
Peter Sjöstrand	M	78	Royal Institute of Technology	-
Li-Rong Zheng	M	-	Royal Institute of Technology	-
Per Anders Storm	M	62	Royal Institute of Technology	-
Mats Williamson	M	66	Royal Institute of Technology	-
Carl Erik Mathias Uhlén	M	70	Royal Institute of Technology	-
Eva Marie Gidlöf	F	67	Royal Institute of Technology	-
Björn O. Nilsson	M	68	Royal Institute of Technology	-
Nils Olle Grinder	M	79	Royal Institute of Technology	-
Tomas Uppgård	M	-	Royal Institute of Technology	-
Alex Jonsson	M	-	Royal Institute of Technology	-
Lars Åke Brodin	M	-	Royal Institute of Technology	-
Helene M. E. Biström	F	62	Royal Institute of Technology	-
Bengt Axel Källbäck	M	79	Royal Institute of Technology	-
Floris Hei	M	-	Royal Institute of Technology	-
Charlotta Liljebris	M	60	XSPRAY PHARMA AB	6 years
Jan-Anders Edvin Månsson	M	72	Royal Institute of Technology	-
Thomas Högberg	M	-	Royal Institute of Technology	-
Jacob Odeberg	M	61	Royal Institute of Technology	-
Eric Gunnar Giertz	M	75	Royal Institute of Technology	-
Monika Cecilia Hermansson	M	62	Royal Institute of Technology	-
Per Ekdunge	M	69	Royal Institute of Technology	32 years
Jan Vikander	M	-	Royal Institute of Technology	-
Gunnar Andersson	M	75	Royal Institute of Technology	-
Semida de Campos Silveira	F	63	Royal Institute of Technology	-
Håkan Lars Mogren	M	79	Royal Institute of Technology	36 years
Pia Marlen Sandvik Wiklund	F	60	Royal Institute of Technology	-
Per Christer Sjöström	M	80	Royal Institute of Technology	13 years
Sami Piittisjärvi	M	32	Royal Institute of Technology	16 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Susanna Helgesen	F	39	XBRANE BIOPHARMA AB	3 years
Niklas Prager	M	54	MEDIVIR AB	3 years
Anne-Lie Sveder	F	-	VITROLIFE AB	1 years
Rolf Classon	M	79	MEDIVIR AB	2 years
Simon Gunnarsson	M	-	Royal Institute of Technology	5 years
Kristian Tryggvason	M	-	BioLamina AB BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.	13 years
Giorgio Chirivi	M	63	XBRANE BIOPHARMA AB	-
Anton Lundqvist	M	54	Royal Institute of Technology	5 years
Daniel Karlgren	M	-	Royal Institute of Technology	5 years
William Jilltoft	M	-	Royal Institute of Technology	6 years
Mårten Gabrielsson	M	-	Royal Institute of Technology	6 years
Johannes Celander	M	-	Royal Institute of Technology	5 years
Adrian Ahmadi	M	-	Royal Institute of Technology	5 years
Christina Malmberg Hägerstrand	F	-	XSPRAY PHARMA AB	-
Sercan Samanci	M	-	Royal Institute of Technology	6 years
Tobias Brodd	M	-	Royal Institute of Technology	5 years
Ylva Ersvik	F	36	Royal Institute of Technology	6 years
Mehdi Lahlou	M	-	Royal Institute of Technology	5 years
Ivan Cohen-Tanugi	M	-	XBRANE BIOPHARMA AB	5 years
Maria Ada Eufemia Forss	F	52	VITROLIFE AB	11 years
Hans Thomas Axelsson	M	65	VITROLIFE AB	12 years
Jane M. Birgitta Stymne Göransson	F	67	MEDIVIR AB	3 years
Carsten Nils Erik Browall	M	66	VITROLIFE AB	7 years
Gustav Ingemar Kihlström	M	71	MEDIVIR AB	6 years
Magnus Nilsson	M	68	VITROLIFE AB	13 years
Nils-Göran Pettersson	M	79	MEDIVIR AB	6 years
Lars Abrahmsén	M	66	Royal Institute of Technology	-
Karin Hansson	M	61	Royal Institute of Technology	5 years
Kjell Rudolf Peter Edman	M	70	XBRANE BIOPHARMA AB	9 years
Claes Magnus Eric Beckman	M	62	Royal Institute of Technology	3 years
Saeid Esmaeilzadeh	M	50	XBRANE BIOPHARMA AB	11 years
Jan Peter Enoksson	M	67	Royal Institute of Technology	3 years
Ronald Eric Long	M	77	MEDIVIR AB	4 years
Barbro Fridén	M	68	VITROLIFE AB	9 years
Alessandro Sidoli	M	65	XBRANE BIOPHARMA AB	3 years
Karin Helena Johansson Wingstrand	F	67	XBRANE BIOPHARMA AB	9 years
Valentina Kosovic	F	-	Royal Institute of Technology	5 years

Statistics

Country	Connections	% of total
Sweden	100	100.00%
United Kingdom	0	-.--%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections